🇺🇸 TRIPLE SULFA in United States

FDA authorised TRIPLE SULFA on 12 September 1945

Marketing authorisations

FDA — authorised 12 September 1945

  • Application: NDA005794
  • Marketing authorisation holder: ORTHO MCNEIL PHARM
  • Local brand name: SULTRIN
  • Indication: TABLET — VAGINAL
  • Status: approved

Read official source →

FDA — authorised 2 June 1976

  • Application: ANDA080280
  • Marketing authorisation holder: ALPHARMA US PHARMS
  • Local brand name: TRIPLE SULFA
  • Indication: SUSPENSION — ORAL
  • Status: approved

Read official source →

FDA — authorised 23 July 1982

  • Application: ANDA087887
  • Marketing authorisation holder: SAVAGE LABS
  • Local brand name: TRYSUL
  • Indication: CREAM — VAGINAL
  • Status: approved

Read official source →

FDA — authorised 15 November 1982

  • Application: ANDA087285
  • Marketing authorisation holder: PADAGIS US
  • Local brand name: TRIPLE SULFA
  • Indication: CREAM — VAGINAL
  • Status: approved

Read official source →

FDA — authorised 9 June 1986

  • Application: ANDA088607
  • Marketing authorisation holder: COSETTE
  • Local brand name: GYNE-SULF
  • Indication: CREAM — VAGINAL
  • Status: approved

Read official source →

FDA

  • Status: approved

FDA

  • Application: ANDA087864
  • Marketing authorisation holder: ALPHARMA US PHARMS
  • Local brand name: TRIPLE SULFA
  • Indication: CREAM — VAGINAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA088462
  • Marketing authorisation holder: PHARMADERM
  • Local brand name: TRIPLE SULFA
  • Indication: TABLET — VAGINAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA088463
  • Marketing authorisation holder: FOUGERA
  • Local brand name: TRIPLE SULFA
  • Indication: TABLET — VAGINAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA080086
  • Marketing authorisation holder: PUREPAC PHARM
  • Local brand name: TRIPLE SULFA
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Application: ANDA086424
  • Marketing authorisation holder: FOUGERA
  • Local brand name: TRIPLE SULFA
  • Indication: CREAM — VAGINAL
  • Status: approved

Read official source →

TRIPLE SULFA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in United States

Frequently asked questions

Is TRIPLE SULFA approved in United States?

Yes. FDA authorised it on 12 September 1945; FDA authorised it on 2 June 1976; FDA authorised it on 23 July 1982.

Who is the marketing authorisation holder for TRIPLE SULFA in United States?

ORTHO MCNEIL PHARM holds the US marketing authorisation.